The Role of Leptin in Preeclampsia: Insights into Pathogenesis and Potential Therapeutic Implications

Preeclampsia is a complex pregnancy disorder characterized by hypertension and organ damage, primarily affecting the maternal cardiovascular and renal systems. Over the years, extensive research has been conducted to understand the underlying mechanisms of preeclampsia, with a particular focus on the role of leptin. Leptin, an adipose-derived hormone, has emerged as a potential contributor to the pathogenesis of preeclampsia. The aim of this chapter is to provide insights into the role of leptin in preeclampsia, including its contribution to the pathogenesis of the disorder.

This chapter provides insights into the role of leptin in preeclampsia, shedding light on its involvement in the development and progression of the disorder. Leptin has been implicated in several key aspects of preeclampsia, including vascular dysfunction, oxidative stress, inflammation, and abnormal placental expression. Its effects on endothelial function and blood pressure regulation make it a crucial factor in the pathophysiology of preeclampsia. Furthermore, this chapter explores the potential therapeutic implications of targeting leptin in the management of preeclampsia. Various strategies, such as leptin receptor antagonists and modulators, are being investigated as potential interventions to mitigate the adverse effects of leptin in preeclampsia. Understanding the intricate role of leptin in preeclampsia opens up possibilities for the development of targeted therapeutic approaches to improve maternal and fetal outcomes. Overall, this chapter provides a comprehensive overview of the role of leptin in preeclampsia, highlighting its significance in the pathogenesis of the disorder. It emphasizes the need for further research to uncover the intricate mechanisms underlying the involvement of leptin and explores potential therapeutic avenues that can be explored to effectively manage preeclampsia and improve maternal and fetal health outcomes.